• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三种 COS 方案的疗效及 AMH 和 AFC 对卵巢储备标志物不一致女性的预测性:19239 例患者的回顾性研究。

Efficacy of three COS protocols and predictability of AMH and AFC in women with discordant ovarian reserve markers: a retrospective study on 19,239 patients.

机构信息

Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China.

出版信息

J Ovarian Res. 2021 Aug 28;14(1):111. doi: 10.1186/s13048-021-00863-4.

DOI:10.1186/s13048-021-00863-4
PMID:34454544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8403432/
Abstract

BACKGROUND

Recent studies have consistently shown that AFC and serum AMH are good predictors of ovarian response and have shown strong correlations. However, it is not unusual for reproductive medicine specialists to encounter discordance between them. This is the first study to investigate the efficacies of the different COS protocols when the AFC and AMH levels are discordant. Based on the association between COS protocols and pregnancy outcomes, we attempt to explain the controversial results and clarify the predictive value of AMH and AFC in this context.

METHODS

19,239 patients undergoing their first fresh in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) cycles with GnRH antagonist protocols, GnRH-a long protocols or GnRH-a ultra-long protocols between January 1, 2016, and December 31, 2019, were enrolled and then divided into four groups in accordance with the boundaries for the AFC and serum AMH level provided by the Poseidon Classification. Our study was divided into two parts. Firstly, we retrospectively compared the effects of the three COS protocols in patients with discordant AMH and AFC. Multivariate logistic regression models were conducted in a forward manner to exclude the influence of confounding factors. Afterward, to increase comparability between Group 2 (low AMH and normal AFC) and Group 3 (normal AMH and low AFC), propensity score matching (PSM) analysis was performed based on age, BMI, the number of embryos transferred, and COS protocol. IVF intermediate and reproductive outcomes were compared between Group 2 and Group 3.

RESULTS

For people with low AMH and normal AFC (Group 2), the number of total oocytes, clinical pregnancy rate (CPR), live birth rate (LBR) and cumulative live birth rate (CLBR) were significantly higher in GnRH-a ultra-long protocol compared with GnRH antagonist protocol. In multivariate logistic regression models, significant associations of COS protocol with fresh LBR and CPR were found after adjusting for age, BMI, AFC, AMH and the number of embryos transferred. Whereas, in patients with normal AMH and low AFC (Group 3), the number of total oocytes, CLBR, LBR and CPR were highest in the long GnRH-a protocol although there was no statistically significant difference. After PSM, the results showed that although oocytes yield and available embryos in patients with normal AMH and low AFC were significantly higher, there was no significant difference in reproductive outcomes between Group 2 and Group 3.

CONCLUSIONS

We found that women with normal AFC and low AMH may benefit from the GnRH-a ultra-long protocol. Nevertheless, for women with normal AMH and low AFC, the long GnRH-a protocol seems to be associated with better clinical outcomes. Furthermore, after eliminating the confounding factors including the COS protocol, we found that AMH can only predict the number of oocytes but not the quality of oocytes when there was discordance between AFC and AMH.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3665/8403432/4868e249b300/13048_2021_863_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3665/8403432/4868e249b300/13048_2021_863_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3665/8403432/4868e249b300/13048_2021_863_Fig1_HTML.jpg
摘要

背景

最近的研究一致表明,AFC 和血清 AMH 是卵巢反应的良好预测指标,并且具有很强的相关性。然而,生殖医学专家经常遇到它们之间的不一致。这是第一项研究,探讨了当 AFC 和 AMH 水平不一致时,不同的 COS 方案的疗效。基于 COS 方案与妊娠结局之间的关联,我们试图解释有争议的结果,并在此背景下阐明 AMH 和 AFC 的预测价值。

方法

本研究纳入了 2016 年 1 月 1 日至 2019 年 12 月 31 日期间接受 GnRH 拮抗剂方案、GnRH-a 长方案或 GnRH-a 超长方案的 19239 名首次新鲜体外受精(IVF)/胞浆内单精子注射(ICSI)周期的患者,然后根据 Poseidon 分类提供的 AFC 和血清 AMH 水平的边界将患者分为四组。我们的研究分为两部分。首先,我们回顾性比较了 AMH 和 AFC 不一致的患者中三种 COS 方案的效果。采用正向逐步多变量逻辑回归模型排除混杂因素的影响。然后,为了增加第 2 组(低 AMH 和正常 AFC)和第 3 组(正常 AMH 和低 AFC)之间的可比性,基于年龄、BMI、移植胚胎数和 COS 方案进行倾向评分匹配(PSM)分析。比较第 2 组和第 3 组之间的 IVF 中期和生殖结局。

结果

对于 AMH 低而 AFC 正常的患者(第 2 组),与 GnRH 拮抗剂方案相比,超长 GnRH-a 方案的总卵母细胞数、临床妊娠率(CPR)、活产率(LBR)和累积活产率(CLBR)显著更高。在调整年龄、BMI、AFC、AMH 和移植胚胎数后,多变量逻辑回归模型显示 COS 方案与新鲜 LBR 和 CPR 显著相关。然而,对于 AMH 正常而 AFC 低的患者(第 3 组),尽管长 GnRH-a 方案的总卵母细胞数、CLBR、LBR 和 CPR 最高,但无统计学差异。PSM 后结果表明,尽管 AMH 正常且 AFC 低的患者的卵母细胞产量和可用胚胎数显著更高,但第 2 组和第 3 组之间的生殖结局无显著差异。

结论

我们发现 AFC 正常而 AMH 低的女性可能受益于超长 GnRH-a 方案。然而,对于 AMH 正常且 AFC 低的患者,长 GnRH-a 方案似乎与更好的临床结局相关。此外,在消除包括 COS 方案在内的混杂因素后,我们发现当 AFC 和 AMH 不一致时,AMH 只能预测卵母细胞的数量,而不能预测卵母细胞的质量。

相似文献

1
Efficacy of three COS protocols and predictability of AMH and AFC in women with discordant ovarian reserve markers: a retrospective study on 19,239 patients.三种 COS 方案的疗效及 AMH 和 AFC 对卵巢储备标志物不一致女性的预测性:19239 例患者的回顾性研究。
J Ovarian Res. 2021 Aug 28;14(1):111. doi: 10.1186/s13048-021-00863-4.
2
Analysis of cumulative live birth rate and perinatal outcomes in young patients with low anti-müllerian hormone levels using two ovulation promotion protocols: A cohort study.两种促排卵方案治疗低抗苗勒管激素水平年轻患者累积活产率及围产结局的分析:一项队列研究。
Front Endocrinol (Lausanne). 2022 Aug 5;13:938500. doi: 10.3389/fendo.2022.938500. eCollection 2022.
3
Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.抗苗勒管激素、促卵泡生成素及窦卵泡计数对接受 GnRH 拮抗剂方案进行体外受精/胚胎移植的女性卵巢刺激结局的预测价值。
Arch Gynecol Obstet. 2014 Dec;290(6):1249-53. doi: 10.1007/s00404-014-3332-3. Epub 2014 Jul 8.
4
Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.基于卵巢储备测试的个体化 FSH 剂量在 IVF/ICSI 起始女性中的应用:一项多中心试验和成本效益分析。
Hum Reprod. 2017 Dec 1;32(12):2485-2495. doi: 10.1093/humrep/dex321.
5
Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?窦卵泡计数和血清抗苗勒管激素的预测价值:对于40岁以上首次接受体外受精治疗的患者,哪一项对预测活产更有优势?
Eur J Obstet Gynecol Reprod Biol. 2018 Feb;221:151-155. doi: 10.1016/j.ejogrb.2017.12.047. Epub 2017 Dec 29.
6
Ovarian response and cumulative live birth rate of women undergoing in-vitro fertilisation who had discordant anti-Mullerian hormone and antral follicle count measurements: a retrospective study.抗苗勒管激素与窦卵泡计数测量结果不一致的接受体外受精女性的卵巢反应及累积活产率:一项回顾性研究
PLoS One. 2014 Oct 14;9(10):e108493. doi: 10.1371/journal.pone.0108493. eCollection 2014.
7
[Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI].[每个取卵周期的累积活产率:体外受精/卵胞浆内单精子注射临床结局评估]
Zhonghua Fu Chan Ke Za Zhi. 2018 Mar 25;53(3):160-166. doi: 10.3760/cma.j.issn.0529-567X.2018.03.004.
8
The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.抗苗勒管激素和窦卵泡计数预测卵母细胞和胚胎潜能。
Eur J Obstet Gynecol Reprod Biol. 2010 Jun;150(2):166-70. doi: 10.1016/j.ejogrb.2010.02.029. Epub 2010 Mar 11.
9
High Serum Anti-Müllerian Hormone Concentrations Are Associated With Poor Pregnancy Outcome in Fresh IVF/ICSI Cycle but Not Cumulative Live Birth Rate in PCOS Patients.高血清抗苗勒管激素浓度与多囊卵巢综合征患者新鲜体外受精/卵胞浆内单精子注射周期的不良妊娠结局相关,但与累积活产率无关。
Front Endocrinol (Lausanne). 2021 May 26;12:673284. doi: 10.3389/fendo.2021.673284. eCollection 2021.
10
The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.抗苗勒管激素在个体化激素剂量算法中的添加并未改善卵巢反应的预测-一项随机对照试验。
Hum Reprod. 2017 Apr 1;32(4):811-819. doi: 10.1093/humrep/dex012.

引用本文的文献

1
Follicular sphericity based on three-dimensional transvaginal ultrasound algorithms predicts ovarian responsiveness to in vitro fertilization.基于三维经阴道超声算法的卵泡球形度可预测卵巢对体外受精的反应性。
J Ovarian Res. 2025 Aug 27;18(1):197. doi: 10.1186/s13048-025-01771-7.
2
Clinical pregnancy outcomes in young women with diminished ovarian reserve undergoing frozen embryo transfer: a comprehensive analysis with exploratory insights into endometrial aging.卵巢储备功能减退的年轻女性行冷冻胚胎移植后的临床妊娠结局:对子宫内膜老化的综合分析及探索性见解
Front Endocrinol (Lausanne). 2025 Jul 29;16:1608200. doi: 10.3389/fendo.2025.1608200. eCollection 2025.
3

本文引用的文献

1
Effectiveness of ultra-long protocol on in vitro fertilization/intracytoplasmic sperm injection-embryo transfer outcome in infertile women with endometriosis: A systematic review and meta-analysis of randomized controlled trials.超长期方案对子宫内膜异位症不孕患者体外受精/胞浆内单精子注射-胚胎移植结局的有效性:系统评价和随机对照试验的荟萃分析。
J Obstet Gynaecol Res. 2021 Apr;47(4):1232-1242. doi: 10.1111/jog.14630. Epub 2021 Jan 11.
2
The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study.促性腺激素释放激素激动剂扳机方案可提高新鲜胚胎移植周期的活产率,但不能提高正常反应者的累积活产率:一项随机对照试验及分子机制研究。
Hum Reprod. 2020 Jun 1;35(6):1306-1318. doi: 10.1093/humrep/deaa086.
3
Zishen Yutai pill ameliorates ovarian reserve by mediating PI3K-Akt pathway and apoptosis level in ovary.
滋肾育胎丸通过介导PI3K-Akt通路及卵巢细胞凋亡水平改善卵巢储备功能。
J Ovarian Res. 2025 Mar 24;18(1):61. doi: 10.1186/s13048-025-01643-0.
4
The association between female age and pregnancy outcomes in patients receiving first elective single embryo transfer cycle: a retrospective cohort study.接受首次选择性单胚胎移植周期的患者中,女性年龄与妊娠结局的关系:一项回顾性队列研究。
Sci Rep. 2024 Aug 19;14(1):19216. doi: 10.1038/s41598-024-70249-1.
5
Nomogram to predict the probability of clinical pregnancy in women with poor ovarian response undergoing in vitro fertilization/ intracytoplasmic sperm injection cycles.预测卵巢反应不良的妇女在体外受精/胞浆内单精子注射周期中临床妊娠概率的列线图。
Arch Gynecol Obstet. 2024 Sep;310(3):1697-1707. doi: 10.1007/s00404-024-07598-9. Epub 2024 Jun 24.
6
Significance of serum AMH and antral follicle count discrepancy for the prediction of ovarian stimulation response in Poseidon criteria patients.血清 AMH 和窦卵泡计数差异对 Poseidon 标准患者卵巢刺激反应预测的意义。
J Assist Reprod Genet. 2024 Mar;41(3):717-726. doi: 10.1007/s10815-024-03050-8. Epub 2024 Feb 15.
7
Effect of BMI on cumulative live birth rates in patients that completed IVF treatment: a retrospective cohort study of 16,126 patients.体重指数对完成体外受精治疗患者累积活产率的影响:一项对16126例患者的回顾性队列研究。
Endocr Connect. 2024 Jan 31;13(3). doi: 10.1530/EC-23-0105. Print 2024 Mar 1.
8
Cumulative live birth rate and neonatal outcomes after early rescue ICSI: a propensity score matching analysis.早期挽救性卵胞浆内单精子注射后的累积活产率及新生儿结局:一项倾向评分匹配分析
Hum Reprod Open. 2023 Nov 23;2023(4):hoad046. doi: 10.1093/hropen/hoad046. eCollection 2023.
9
Comparison between the modified long gonadotropin-releasing hormone agonist protocol and the non-downregulation protocol in POSEIDON groups: a propensity score matching retrospective cohort study.改良长效促性腺激素释放激素激动剂方案与 POSEIDON 组非下调方案的比较:倾向评分匹配回顾性队列研究。
Front Endocrinol (Lausanne). 2023 Nov 9;14:1189357. doi: 10.3389/fendo.2023.1189357. eCollection 2023.
10
Cut-off point of mature oocyte for routine clinical application of rescue IVM: a retrospective cohort study.常规临床应用挽救 IVM 的成熟卵母细胞截止点:回顾性队列研究。
J Ovarian Res. 2023 Nov 22;16(1):226. doi: 10.1186/s13048-023-01294-z.
The effectiveness of different down-regulating protocols on in vitro fertilization-embryo transfer in endometriosis: a meta-analysis.不同下调方案对子宫内膜异位症体外受精-胚胎移植的有效性:一项荟萃分析。
Reprod Biol Endocrinol. 2020 Feb 29;18(1):16. doi: 10.1186/s12958-020-00571-6.
4
Effect of Switching from a Progestin-Primed Ovarian Stimulation Protocol to a Modified Ultra-Long Protocol Among Women Who Had 1 Progestin-Primed Ovarian Stimulation (PPOS) Failure Verses Those Who Had 2 PPOS Failures.对于孕激素预处理促排卵(PPOS)方案失败者中仅 1 次失败者与 2 次失败者,从孕激素预处理方案转换为改良超长方案对其的影响。
Med Sci Monit. 2020 Jan 18;26:e918705. doi: 10.12659/MSM.918705.
5
Low Dose Growth Hormone Adjuvant Treatment With Ultra-Long Ovarian Stimulation Protocol in Poor Responders Showed Non-inferior Pregnancy Outcome Compared With Normal Responders.低剂量生长激素辅助超长方案卵巢刺激对卵巢低反应者的治疗效果显示,与正常反应者相比,其妊娠结局无劣效性。
Front Endocrinol (Lausanne). 2019 Dec 20;10:892. doi: 10.3389/fendo.2019.00892. eCollection 2019.
6
Discordance between antral follicle counts and anti-Müllerian hormone levels in women undergoing in vitro fertilization.在接受体外受精的女性中,窦卵泡计数与抗苗勒氏管激素水平之间的差异。
Reprod Biol Endocrinol. 2019 Jul 4;17(1):51. doi: 10.1186/s12958-019-0497-4.
7
Decision analysis about the cost-effectiveness of different in vitro fertilization-embryo transfer protocol under considering governments, hospitals, and patient.考虑政府、医院和患者因素下不同体外受精-胚胎移植方案成本效益的决策分析
Medicine (Baltimore). 2019 May;98(19):e15492. doi: 10.1097/MD.0000000000015492.
8
Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues.血清抗苗勒管激素浓度与窦卵泡计数之间的不一致:不仅仅是技术问题。
Hum Reprod. 2018 Jun 1;33(6):1141-1148. doi: 10.1093/humrep/dey098.
9
GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type.促性腺激素释放激素拮抗剂与长激动剂方案在体外受精中的应用:一项考虑患者类型的系统评价和荟萃分析。
Hum Reprod Update. 2017 Sep 1;23(5):560-579. doi: 10.1093/humupd/dmx017.
10
Comparisons of GnRH antagonist protocol versus GnRH agonist long protocol in patients with normal ovarian reserve: A systematic review and meta-analysis.正常卵巢储备患者中GnRH拮抗剂方案与GnRH激动剂长方案的比较:一项系统评价和荟萃分析。
PLoS One. 2017 Apr 24;12(4):e0175985. doi: 10.1371/journal.pone.0175985. eCollection 2017.